Power Law company profile

AIM Vaccine

Biotech & Life Sciences · Daxing District, China · Founded 2011 · IPO 2022 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$548M

Market cap · Apr/2026

Revenue

$160M

Latest reported FY

Global footprint

Where AIM Vaccine has talent and traffic

Web traffic by country

23K monthly visits
across markets

🇺🇸 United States11.3%

🇨🇦 Canada4.8%

🇮🇳 India3%

Top 3 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo